Consider Eurofins DiscoverX’s custom development capabilities for custom cell lines, assays, & enzyme development.
Cell-Based Assay Solutions to Accelerate Your Drug Discovery & Development Programs with Confidence
Assays, Cell Lines, & Reagents: From Discovery to Commercial Release, Small & Large Molecules, Ready-to-use & Optimized Products
Developing small molecule and biologic therapeutics presents unique challenges at each development phase. This development requires the knowledge, experience, and a broad range of assays and reagents to understand the therapeutics' structure, activity, and mechanism of action (MOA). Eurofins DiscoverX® provides the most comprehensive portfolio of cell line assay kits, stable cell lines, easy-to-use validated functional and binding assay kits, recombinant proteins, and optimized reagents, all developed and manufactured to support your drug discovery and development journey every step of the way. These simple, assay ready kits (bioassays and eXpress assay kits) are sensitive, use homogeneous, no wash protocols, and provide quantitative and reproducible results. Several customized solutions can be delivered for program-specific needs, drawing on our deep expertise in cell line engineering, assay design, method qualification, and cell and protein production.
Support at Every Stage, From Discovery to QC Lot Release
At Eurofins DiscoverX, we are committed to enabling and accelerating your multi-modality drug discovery and development programs from Discovery, through Development, and into Commercial Release & Stability. Discover for yourself how Eurofins DiscoverX enables you to accelerate your therapeutics development. Advance confidently.
Product Highlights
- Enabling Technologies and Robust Assays – Improve productivity and effectiveness of your target validation, screening, lead optimization, and structure-activity relationships campaigns to accelerate the advancement of new therapeutics
- Comprehensive Portfolio – The industry's largest available portfolio of cell-based functional and binding assays, cell line assays, and proteins covering the top therapeutic target classes including GPCRs, kinases, checkpoint and cytokine receptors, ion channels, and more
- Support Every Step of the Way – End-to-end support for your programs from discovery, through development, to commercial release and stability QC lot release testing
- Deep Expertise – Over two decades of experience in developing cell-based assays to support your specific therapeutic development stage
Highlights
Resources
Related Pages
Highlights
Supporting Your Journey with Cell-Based Assays and Capabilities for Characterization, Screening, Profiling, Potency, and Lot Release Programs
The Eurofins DiscoverX portfolio of high-quality products and custom assays enables you to expedite your research, and move your candidate through the drug discovery pipeline faster.
Global Programs using Eurofins DiscoverX Bioassays for Potency, Stability, and NAb Testing for Drug Release
Eurofins DiscoverX bioassays are fit-for-purpose for implementation in QC lot-release for potency testing, helping to accelerate the time-to-market for therapeutics by 6 to 9 months, and ensuring high lot-to-lot reproducibility and accuracy for the life of the program. These assays can be readily transferred and implemented in potency and stability programs that typically happen under GMP conditions at the sponsors’ testing sites or partner CRO/CDMO sites. Access off-the-shelf bioassay kits that have been successfully implemented in 100+ global programs covering popular and unique druggable target classes. NA = North America, EU = Europe, APAC = Asia Pacific, and NAb = Neutralizing Antibody.
Assays for Screening, Profiling, Potency, and Lot Release Programs
Confidently expedite regulatory approval of your drug candidates while ensuring consistency and comparability in their evaluation across different regulatory jurisdictions, facilitating global drug development efforts.